Ascentage Pharma to Present at 43rd Annual J.P. Morgan Healthcare Conference

December 27, 2024 | 08:44

(0) user say

Ascentage Pharma, a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies.

ROCKVILLE, Md. and SUZHOU, China, Dec. 27, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that its Chairman and CEO, Dr. Dajun Yang, has accepted an invitation to present on the company's progress and prospects under its patient-centric global innovation strategy, at 1:15 PM, January 16, 2025, Pacific Time (5:15 AM, January 17, 2025, Beijing Time) at the 43rd Annual J.P. Morgan Healthcare Conference.

The annual J.P. Morgan Healthcare Conference is the largest and most informative event for the global pharmaceutical industry and the investment community. This year, the conference will take place in San Francisco, CA, the United States, on January 13-16, 2025.

Time:

January 16, 2025; 1:15-1:40 PM, Pacific Time

(January 17, 2025; 5:15-5:40 AM, Beijing Time)

Speaker:

Dr. Dajun Yang, Chairman and CEO of Ascentage Pharma

You may sign up for the conference and listen to a live webcast of the speech at:

https://jpmorgan.metameetings.net/events/healthcare25/sessions/58522-ascentage-pharma-group-international/webcast?gpu_only=true&kiosk=true

By PR Newswire

Ascentage Pharma

What the stars mean:

★ Poor ★ ★ Promising ★★★ Good ★★★★ Very good ★★★★★ Exceptional